Bringing the Oncology Community Together

Dr. Mills on the Development of Combination Therapies

Gordon B. Mills, MD, PhD
Published Online: Friday, October 7, 2011
Gordon B. Mills, MD, PhD, chairman, Department of Systems Biology, chief, Section of Molecular Therapeutics, Professor of Medicine and Immunology at the University of Texas MD Anderson Cancer Center, discusses utilizing systems biology for the development of new combination therapies.

Homeostasis in normal cells results in a rewiring of signaling pathways in order to maintain equilibrium. The homeostatic mechanism is not as strong in cancer cells but there is still a response that occurs when a targeted therapeutic is introduced.

Cancer cells enact a stress program in order to survive the stress of the therapeutic. This reaction can be exploited and used to create combinations that not only target the original tumor cells but also prevent resistance by targeting the compensation mechanism.

Mills explains that research is currently being focused on combinations that will be the most effective. The studies seek to establish a therapeutic index by examining systems biology for various combinations based on a comparison between the toxicity and efficacy of the treatment.

Related Articles
Should Your Practice Join a Provider-Based Research Network?
Provider-based research networks (PBRNs) make clinical trials available to community-based practices.
AHRQ Report Says Evaluating Survivorship Programs Difficult Because of ‘Idiosyncrasies’
Efforts to evaluate cancer survivorship programs are a daunting task according to a technical brief issued by the Agency for Healthcare Research and Quality.
The Promise of ACOs and Bundled Payments Remains Cloudy
Evidence that demonstrates how best to implement newer value-based purchasing (VBP) programs like accountable care organizations (ACOs) and bundled payments is lacking
Most Popular Right Now
More Reading
External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc
OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.